Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti – 24 July 2018 – Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to evaluate whether CAP is associated with the development of clinically relevant events in cACLD.

Ricky H. Bhogal, Christopher J. Weston, Susanne Velduis, Henri G. D. Leuvenink, Gary M. Reynolds, Scott Davies, Luu Nyguet‐Thin, Mohammed Alfaifi, Emma L. Shepard, Yuri Boteon, Lorraine Wallace, Ye H. Oo, David H. Adams, Darius F. Mirza, Hynek Mergental, Gillian Muirhead, Barnaby T. F. Stephenson, Simon C. Afford – 24 July 2018 – Ischemia/reperfusion injury (IRI) is the main cause of complications following liver transplantation. Reactive oxygen species (ROS) were thought to be the main regulators of IRI.

Cameron I. Wells, John L. McCall, Lindsay D. Plank – 24 July 2018 – Sarcopenia as defined by reduced skeletal muscle area (SMA) on cross‐sectional abdominal imaging has been proposed as an objective measure of malnutrition, and it is associated with both wait‐list mortality and posttransplant complications in patients with cirrhosis. SMA, however, has never been validated against the gold standard measurement of total body protein (TBP) by in vivo neutron activation analysis (IVNAA).

23 July 2018

David A. Brenner – 23 July 2018

Kohei Ogawa, Kenya Kamimura, Shuji Terai – 23 July 2018

Saira Khaderi, Norman Sussman, Fasiha Kanwal – 23 July 2018

23 July 2018

Riccardo Superina – 23 July 2018

Juan P. Arab, Marco Arrese – 23 July 2018